[Tolerance and clinical effects of ethynodiol diacetate in massive doses (50 to 100 mg per day) in treatment of advanced uterine and ovarian cancer (10 cases of advanced cancer)].
D000230:Adenocarcinoma / Q000188:drug therapy*; D000368:Aged; D002277:Carcinoma / Q000188:drug therapy*; D005040:Ethynodiol Diacetate / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D013997:Time Factors; D014594:Uterine Neoplasms / Q000188:drug therapy*
D005040:Ethynodiol Diacetate
Tolérance et effets cliniques du diacétate d'étynodiol à doses massives (50 à 100 mg par jour) dans le traitement des cancers avancés de l'utérus et de l'ovaire, (à propos de 10 observations de cancers anancés)